Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)

Podobne zapisy

• Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
  od: Xue, L, i wsp.
  Wydane: (2018)
• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  od: Sandham, D, i wsp.
  Wydane: (2019)
• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  od: Chen, W, i wsp.
  Wydane: (2018)
• Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
  od: Hardman, C, i wsp.
  Wydane: (2019)
• Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
  od: Veit J. Erpenbeck, i wsp.
  Wydane: (2016-12-01)